Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TN › Maryville › NPI 1053335729
Lab

Molecular Pathology Laboratory Network INC

Molecular Pathology Laboratory Network INC was paid $61K by Medicaid between Jan 2018 and Nov 2024, across 5 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 63% of everything it billed.

33Billing provider infoMOLECULAR PATHOLOGY LABORATORY NETWORK INC
MARYVILLE, TN 37804
33aNPI1053335729assigned 07/27/2006
28Total paid$61K
24GClaims1,671
24DCodes billed5
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Tennessee

Rank by total paid#41 of 70
Median peer was paid$141K
This provider vs. median0.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018189$3K
2019102$2K
202040$2K
2021746$28K
2022511$24K
202356$1K
2024incomplete27$979.04
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 63% 599 440 $39K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 19% 578 420 $12K
88189 15% 446 377 $9K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 1.5% 36 36 $916.57
81270 1.2% 12 12 $700.80

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHUBBARD, ROGER (OWNER, CEO)